| scholarly article | Q13442814 |
| P50 | author | Satoshi Tsukushi | Q79698604 |
| P2093 | author name string | Naoki Ishiguro | |
| Yoshihiro Nishida | |||
| Hideshi Sugiura | |||
| Kenji Yamada | |||
| Eiji Kozawa | |||
| Eisuke Arai | |||
| Hiroshi Urakawa | |||
| Naohisa Futamura | |||
| Yoshihisa Yamada | |||
| P2860 | cites work | Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas | Q74118678 |
| Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group | Q80845732 | ||
| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 | ||
| Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial | Q32073183 | ||
| Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial | Q33340568 | ||
| Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program | Q33406382 | ||
| Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults | Q33446946 | ||
| Osteosarcoma over the age of forty. | Q34530178 | ||
| Malignant fibrous histiocytoma.An Analysis of 200 Cases | Q34622825 | ||
| Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. | Q34638074 | ||
| Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. | Q34642231 | ||
| Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report | Q36688734 | ||
| Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese Musculoskeletal Oncology Group | Q37454634 | ||
| cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma | Q40876948 | ||
| Doxorubicin in disseminated osteosarcoma | Q43741264 | ||
| Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial | Q44078017 | ||
| Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma | Q44214222 | ||
| Prognosis of extremity osteosarcoma in patients aged 40-60 years: a cohort/case controlled study at a single institute | Q51775757 | ||
| Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999 | Q56995093 | ||
| Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report | Q57008750 | ||
| De Novo Osteogenic Sarcoma in Patients Older Than Forty | Q60021779 | ||
| The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity | Q68879882 | ||
| Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy | Q69111750 | ||
| Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study | Q73042273 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| ifosfamide | Q418560 | ||
| P304 | page(s) | 2485-2488 | |
| P577 | publication date | 2014-09-26 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients | |
| P478 | volume | 8 |
| Q91785324 | Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma |
| Q99633027 | Definitive surgery of primary lesion should be prioritized over preoperative chemotherapy to treat high-grade osteosarcoma in patients aged 41-65 years |
| Q92798732 | Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery |
Search more.